- Kristi Powers
Choose the health content that’s right for you, and get it delivered right in your inbox.
A new genetic test for patients with colorectal cancer, being studied at AdventHealth, can detect if a patient has cancer from a simple blood draw. The groundbreaking test could allow patients to avoid chemotherapy after having surgery to remove a tumor. The test searches for circulating tumor DNA (ctDNA), which is a sequencing technology that can detect very small amounts of tumor DNA in the body’s circulatory system.
“What we knew is that a lot of those patients were cured with surgery alone. We just didn’t have a way to know which ones had microscopic cancer left in the blood, who needed chemo and who did not,” said Dr. Mohamedtaki Tejani, medical oncologist and director of the Gastrointestinal Oncology program at the AdventHealth Cancer Institute and the AdventHealth Research Institute, told the Orlando Sentinel.
Colorectal cancer is the fourth most common cancer diagnosed in the U.S. and the second leading cause of cancer-related deaths. Dr. Tejani is leading the AdventHealth site with two National Cancer Institute clinical trials that aim to harness this sequencing technology to improve patient care. The trial related to Stage 3 colon cancer and the BESPOKE study are currently enrolling participants through a referral process with the AdventHealth Gastrointestinal Oncology Program. Click the link for each study for more information on how to enroll.
In the future, Dr. Tejani hopes this genetic test, which has to be ordered by a physician, can also be used to prescreen for very early-stage colon cancer, and also more effectively treat other cancers, such as gynecologic or pancreatic cancers.
Read the full Orlando Sentinel story here.
Recent News
One in six Black men will develop prostate cancer in their lifetime, according to ZERO Prostate Cancer.
Doctors at the AdventHealth Digestive Health and Surgery Institute are trying to better understand why men under 50 are seeing higher colorectal cancer mortality rates and say there are certain risk...
AdventHealth hospitalist Dr. Joe Jones revives a patient experiencing a sudden heart attack.
A genetic test, originally conducted to help better understand her daughter's diagnosis, revealed Samantha Arceneaux carries a genetic variant that virtually guarantees she will develop an aggressive...
AdventHealth and Junior Achievement of Central Florida proudly announce a partnership to unite efforts to inspire Central Florida students to pursue a career in the health care industry. Together, the...
AdventHealth joined the University of Central Florida and several community partners last week to celebrate the groundbreaking of the Dr. Phillips Nursing Pavilion. This state-of-the-art building will...
Kidney-tumor patients have an innovative new treatment option, first performed recently by a surgical team at AdventHealth Celebration.
The two organizations, local officials, and student athletes celebrated the groundbreaking partnership at the iconic Jackie Robinson Ballpark.
The new SMILE with Stella Tremonti Down Syndrome Clinic is the only lifespan program of its kind in the Southeast.
Chuck File knew something was horribly wrong, as he walked into his gym to workout in October of 2023.
The accreditation recognizes the hospital’s commitment to excellence in patient care and safety.
As the world rang in 2024, AdventHealth for Women welcomed the very first babies of the new year. Meet Jose, Huxli, Michael, Isaiah and Harlynn!